Sandra Kuniyoshi is a Neurology physician affiliated with Arizona State University. OpenAlex indexes 29 publications with 786 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3201 W Peoria Ave
Suite C500
Phoenix, AZ 850294608
Telephone
602-439-1200Registry record last updated 30 Nov 2007.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20251 payment
- ABBVIE INC.Program year20241 payment
- MDD US Operations, LLCProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
89.4%Aromatic Amino Acid Decarboxylation Inhibitor32.5%Carbidopa-Levodopa78%Rytary22%Part D≥62 patientsCalcitonin gene-related peptide (CGRP) antagonists8.2%Aimovig Autoinjector74%Emgality Pen26%Part D<11 patients+ 12 more classes in this area
Cardiovascular
6.6%Beta blocker5%Propranolol Hcl100%Part D≥16 patientsCalcium channel blocker1.6%Verapamil Hcl100%Part D<11 patientsMusculoskeletal
2.8%gamma-Aminobutyric Acid-ergic Agonist1.5%Baclofen100%Part D<11 patientsNeuromuscular Blocker1.3%Botox100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pathologic and Imaging Correlates of Cognitive Deficits in Multiple Sclerosis
Cognitive and Behavioral Neurology
2014 - Cognitive Impairment in Neurological Diseases: Lessons from Apolipoprotein E
Journal of Alzheimer s Disease
2013 - APOE ε4 Is Associated With Exacerbation of Cognitive Decline in Patients With Multiple Sclerosis
Cognitive and Behavioral Neurology
2011 - A new EAE model of brain demyelination induced by intracerebroventricular pertussis toxin
Biochemical and Biophysical Research Communications
2008
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”